Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis

Biological Psychiatry

Volumn 56, Issue 3, 2004, Pages 169-176

  Korostishevsky, Michael ^a   Kaganovich, Miryam ^a   Cholostoy, Alina ^a   Ashkenazi, Maya ^a   Ratner, Yael ^d   Dahary, Dvir ^b   Bernstein, Jeanne ^b   Bening Abu Shach, Ullrike ^a   Ben Asher, Edna ^c   Lancet, Doron ^c   Ritsner, Michael ^d   Navon, Ruth ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b JB) ^*  (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d SHA'AR MENASHE MENTAL HEALTH CENTER   (Israel)

Author keywords

Ashkenazi Jews; dorsolateral prefrontal cortex; linkage disequilibrium; real time polymerase chain reaction; Schizophrenia; susceptibility genes

Indexed keywords

GENOMIC DNA; PROTEIN; PROTEIN G72; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CADAVER; CONTROLLED STUDY; CORRELATION ANALYSIS; ETHNOLOGY; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; JEWS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMORTEM CHANGES; PREFRONTAL CORTEX; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 3242755008     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.04.006     Document Type: Article

References (48)

1. Abramson J.H., Gahlinger P.M. Computer Program for Epidemiologists. PEPI version 3. 1999;Brixton Books, London
2. Ankory Z. Origin and history of Ashkenazi Jewry (8th to 18th century). Goodman R.M., Motulsky A.G. Genetic Disease Among Ashkenazi Jews. 1979;Raven Press, New York
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3th ed :1987;American Psychiatric Association, Washington, DC. 121-139
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed :1994;American Psychiatric Association, Washington, DC
5. Andreasen N.C. Symptoms, signs, and diagnosis of schizophrenia. Lancet. 346:1995;477-481
6. Badner J.A., Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry. 7:2002;405-411
7. Ball T.B., Plummer F.A., HayGlass K.T. Improved mRNA quantitation in LightCycler RT-PCR. Int Arch Allergy Immunol. 130:2003;82-86
8. Behar DM, Hammer MF, Garrigan D, Villems R, Bonne-Tamir B, Richards M, et al (2004): MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population. Eur J Hum Genet 12:355-364
9. Blackwood E.M., Kadonaga J.T. Going the distance A current view of enhancer action. Science. 3:1998;61-63
10. Blouin J.L., Dombroski B.A., Nath S.K., Lasseter V.K., Wolyniec P.S., Nestadt G., et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet. 20:1998;70-73
11. Bonne-Tamir B., Adam A. Genetic Diversity Among Jews Diseases and Markers at the DNA Level. 1992;Oxford University Press, New York
12. Brzustowicz L.M., Honer W.G., Chow E.W., Little D., Hogan J., Hodgkinson K., et al. Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet. 65:1999;1096-1103
13. Carmichael G.G. Antisense starts making more sense. Nat Biotechnol. 21:2003;371-372
14. Christian S.L., McDonough J., Liu C.Y., Shaikh S., Vlamakis V., Badner J.A., et al. An evaluation of the assembly of an approximately 15-Mb region on human chromosome 13q32-q33 linked to bipolar disorder and schizophrenia. Genomics. 79:2002;635-656
15. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A. 99:2002;13675-13680
16. Cloninger C.R. The discovery of susceptibility genes for mental disorders. Proc Natl Acad Sci U S A. 99:2002;13365-13367
17. Excoffier L., Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 12:1995;921-927
18. Gottesman I.I. Schizophrenia Genesis The Origins of Madness. 1991;W.H. Freeman, New York
19. Guo S., Thomson E. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 48:1992;361-372
20. Hattori E., Liu C., Badner J.A., Bonner T.I., Christian S.L., Maheshwari M., et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet. 72:2003;1131-1140
21. Iseli C., Stevenson B.J., Desouza S.J., Samaia H.B., Camargo A.A., Buetow K.H., et al. Long-range heterogeneity at the 3′ ends of human mRNAs. Genome Res. 7:2002;1068-1074
22. Kaganovich M., Peretz A., Ritzner M., Bening Abu-Shach U., Attali B., Navon R. Is WKL1 gene associated with schizophrenia? Am J Med Genet. 125B:2004;31-37
23. Komlos L., Korostishevsky M., Livni E., Halbrecht I., Vardimon D., Ben-Rafael Z., et al. Possible sex-correlated transmission of maternal class I HLA haplotypes. Eur J Immunogenet. 24:1997;169-177
24. Konradi C., Heckers S. Molecular aspects of glutamate dysregulation Implications for schizophrenia and its treatment. Pharmacol Ther. 97:2003;153-179
25. Levinson D.F., Holmans P., Straub R.E., Owen M.J., Wildenauer D.B., Gejman P.V., et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q Schizophrenia linkage collaborative group III. Am J Hum Genet. 67:2000;652-663
26. Lin M.W., Curtis D., Williams N., Arranz M., Nanko S., Collier D., et al. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32. Psychiatr Genet. 5:1995;117-126
27. Little D.P., Braun A., Darnhofer-Demar B., Frilling A., Li Y., McIver R.T. Jr, et al. Detection of RET proto-oncogene codon 634 mutations using mass spectrometry. J Mol Med. 75:1997;745-750
28. Little D.P., Braun A., Darnhofer-Demar B., Koster H. Identification of apolipoprotein E polymorphisms using temperature cycled primer oligo base extension and mass spectrometry. Eur J Clin Chem Clin Biochem. 35:1997;545-548
29. Mazumder B., Seshadri V., Fox P.L. Translational control by the 3′-UTR The ends specify the means. Trends Biochem Sci. 28:2003;91-98
30. McGinnis R., Shifman S., Darvasi A. Power and efficiency of TDT and case-control design for association scans. Behav Genet. 32:2002;135-144
31. Mothet J.P., Parent A.T., Wolosker H., Bradu R.O., Linden D.J., Ferris C.D., et al. D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 97:2000;4926-4931
32. Nebel A., Filon D., Brinkmann B., Majumder P.P., Faerman M., Oppenheim A. The Y chromosome pool of Jews as part of the genetic landscape of the middle east. Am J Hum Genet. 69:2001;1095-1112
33. Ostrer H. A genetic profile of contemporary Jewish populations. Nat Rev Genet. 2:2001;891-898
34. Pennisi E. Gene counters struggle to get the right answer. Science. 301:2003;1040-1041
35. Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 155:2000;945-959
36. Raymond M., Rousset F. An exact test for population differentiation. Evolution. 49:1995;1280-1283
37. Sasieni P.D. From genotypes to genes Doubling the sample size. Biometrics. 53:1997;1253-1261
38. Schneider S, Roessli D, Excoffier L (2000): A Software for Population Genetic Data Analysis. Manual Arlequin, Version 2.00. Geneva: University of Geneva
39. Shaw S.H., Kelly M., Smith A.B., Shields G., Hopkins P.J., Loftus J., et al. A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet. 81:1998;364-376
40. Slatkin M. Linkage disequilibrium in growing and stable population. Genetics. 137:1994;331-336
41. Slatkin M., Excoffier L. Testing for linkage disequilibrium in genotypic data using the EM algorithm. Heredity. 76:1996;377-383
42. Thomas M.G., Weale M.E., Jones A.L., Richards M., Skorecki K., Torroni A., et al. Founding mothers of Jewish communities Geographically separated Jewish groups were independently founded by very few female ancestors. Am J Hum Genet. 70:2002;1411-1420
43. Torrey E.F., Webster M., Knable M., Johnson N., Yolken R.H. The Stanely Foundation Brain Collection and Neuropathology Consortium. Schizophr Res. 44:2000;151-155
44. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science. 291:2001;1304-1351
45. Wilson A.F., Sorant A.J.M. Equivalence of single- and multilocus markers Power to detect linkage with composite markers derived from biallelic loci. Am J Hum Genet. 66:2000;1610-1615
46. Yelin R., Dahary D., Sorek R., Levanon E.Y., Goldstein O., Shosan A., et al. Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol. 21:2003;379-386
47. Zlotogora J. High frequencies of human genetic diseases Founder effect with genetic drift or selection? Am J Med Genet. 49:1994;10-13
48. Zlotogora J., Bach G., Munnich A. Molecular basis of mendelian disorders among Jews. Mol Genet Metab. 69:2000;169-180